International Stem Cell CORP

ISCO

International Stem Cell CORP

ISCO

Insider Sentiment (TTM):

Last Purchase:2019-01-21Last Sale:2019-04-18Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2023-03-31Institutional Shares Owned:20Shares Outstanding:8,004,389Institutional Ownership Pct.:0.00%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash	1	1	1	1	1	1	1	1	1	1	2	1
Accounts Receivable Net Current	1	1	1	1	1	1	1	1	1	1	1	1
Inventory Net	2	2	2	2	2	1	1	1	1	1	1	1
Prepaid Expense And Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	4	4	3	4	4	4	4	3	4	4	4	4
Inventory Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	1	1	1	1	1	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	0	0	0	0	1	1	0	0	0	1	1	1
Assets	5	5	5	5	6	6	5	5	6	5	5	6
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	0	0	0	0	0	0	0	0	0	0	0	0
Accrued Liabilities Current	1	1	0	0	1	1	1	0	1	1	0	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Notes Payable Current	3	3	3	3	3	3	3	3	4	3	3	3
Liabilities Current	5	5	5	5	5	5	5	5	5	5	5	5
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	1
Liabilities	5	5	5	5	5	5	5	5	5	5	5	5
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	107	107	107	107	107	107	107	107	107	106	106	106
Retained Earnings Accumulated Deficit	-111	-111	-111	-111	-111	-111	-111	-111	-111	-111	-110	-110
Stockholders Equity	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4
Liabilities And Stockholders Equity	5	5	5	5	6	6	5	5	6	5	5	6
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	120	120	120	120	120	120	120	120	120	120	120	120
Common Stock Shares Issued	8	8	8	8	8	8	8	8	8	8	8	8
Shares Outstanding	8	8	8	8	8	8	8	8	8	8	8	8

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	0.00%	11.11%	44.44%	-	-	-	-	-	-	-	-	-
2025	18.18%	18.18%	45.45%	-6.67%	-13.33%	0.00%	-12.50%	-12.50%	-12.50%	-12.50%	6.25%	6.25%
2024	0.00%	22.22%	-22.22%	-14.29%	-14.29%	-14.29%	66.67%	50.00%	83.33%	-8.33%	-8.33%	0.00%
2023	-	-	-	-	-	-	-8.33%	-16.67%	-8.33%	-30.00%	-10.00%	-20.00%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.79	0.76	0.74	0.80	0.78	0.75	0.76	0.74	0.76	0.72	0.73	0.78
Quick Ratio	0.41	0.34	0.37	0.43	0.41	0.45	0.49	0.42	0.42	0.41	0.45	0.44
Working Capital	-1.06M	-1.24M	-1.17M	-921.00K	-1.10M	-1.27M	-1.13M	-1.23M	-1.21M	-1.37M	-1.31M	-1.02M
Leverage & Debt
Debt to Equity	-1.18	-1.20	-1.13	-1.26	-1.32	-1.32	-1.22	-1.22	-1.32	-1.25	-1.26	-1.35
Interest Coverage TTM	-111.00	-48.40	-44.50	16.17	-12.43	-2.63	-0.93	-5.07	-3.96	-6.06	-4.77	-1.29
Debt Ratio	0.99	0.98	0.95	0.90	0.93	0.96	0.93	0.95	0.95	0.99	0.98	0.92
Efficiency & Turnover
Asset Turnover TTM	1.79	1.73	1.82	1.80	1.65	1.65	1.72	1.58	1.46	1.46	1.48	1.56
Days Sales Outstanding TTM	39.52	32.27	35.72	32.94	37.90	29.79	32.78	28.33	32.28	30.76	30.95	23.46
Receivables Turnover TTM	9.24	11.31	10.22	11.08	9.63	12.25	11.13	12.88	11.31	11.87	11.79	15.56
Per Share Metrics
Diluted EPS TTM	-0.07	-0.05	-0.05	-0.01	-0.03	-0.03	-0.03	-0.08	-0.09	-0.04	-0.02	0.04
Free Cash Flow Per Share TTM	0.04	-0.02	-0.00	-0.02	0.00	0.03	-0.02	0.01	-0.01	0.06	0.11	0.10
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	54.96%	56.98%	55.68%	57.86%	57.80%	57.41%	58.57%	57.35%	58.62%	58.58%	59.16%	58.54%
Operating Profit Margin TTM	-4.67%	-2.61%	-2.93%	1.03%	-0.95%	-1.16%	-0.75%	-6.37%	-6.61%	-10.76%	-8.51%	-2.14%
Net Profit Margin TTM	-6.12%	-4.11%	-4.59%	-0.93%	-2.62%	-2.76%	-2.30%	-7.95%	-8.22%	-3.97%	-1.68%	4.20%
Growth Metrics
Net Revenue Growth (1Y)	3.40%	2.21%	0.17%	10.12%	10.56%	16.00%	16.64%	2.38%	3.25%	-5.02%	-4.78%	9.71%
Net Income Growth (1Y)	141.49%	52.19%	100.00%	-87.17%	-64.77%	-19.29%	59.54%	-293.71%	-595.65%	-12.64%	-60.42%	-149.65%
EPS Growth (1Y)	141.49%	52.19%	100.00%	-87.17%	-64.77%	-19.29%	59.54%	-293.71%	-595.65%	-12.64%	-60.42%	-149.65%
Valuation Metrics
P/E TTM	-2.61	-3.56	-2.68	-11.96	-5.31	-3.83	-3.06	-0.71	-0.70	-2.57	-3.67	2.74
P/B TTM	-0.36	-0.32	-0.28	-0.28	-0.33	-0.24	-0.16	-0.12	-0.12	-0.19	-0.11	-0.25
P/S TTM	0.16	0.15	0.12	0.11	0.14	0.11	0.07	0.06	0.06	0.10	0.06	0.12
Market Cap	1.52M	1.36M	1.12M	1.04M	1.28M	960.53K	640.35K	480.26K	480.26K	800.44K	480.26K	960.53K
Enterprise Value	3.69M	3.65M	3.47M	3.38M	3.63M	2.94M	2.81M	2.53M	2.71M	2.90M	2.35M	2.95M
Calculated Values
Free Cash Flow TTM	333.00K	-159.00K	-35.00K	-139.00K	35.00K	270.00K	-153.00K	83.00K	-89.00K	447.00K	849.00K	764.00K
Net Debt	2.17M	2.29M	2.35M	2.34M	2.35M	1.98M	2.17M	2.05M	2.23M	2.10M	1.87M	1.99M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2019-04-18Sale

Owner: Maier, Paul V

Title: -

Shares: 1,350

Price/Share: $1.25

Value: $1,687.50

Shares Owned: 31,710

Relationship: Director

Ownership: Direct

2019-01-21Purchase

Owner: Semechkin, Andrey

Title: Chief Executive Officer

Shares: 599,222

Price/Share: $1.75

Value: $1,048,638.50

Shares Owned: 4,034,594

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2018-12-04Sale

Owner: Garnette, Sophia

Title: VP, Legal Affairs & Operations

Shares: 10,636

Price/Share: $1.54

Value: $16,379.44

Shares Owned: 267

Relationship: Officer

Ownership: Direct

2018-12-03Sale

Owner: Kern, Russell

Title: EVP and CSO

Shares: 1,800

Price/Share: $1.67

Value: $3,006.00

Shares Owned: 178,398

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2018-10-02Sale

Owner: Garnette, Sophia

Title: VP, Legal Affairs & Operation

Shares: 1,494

Price/Share: $1.58

Value: $2,360.52

Shares Owned: 267

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2019-04-18	Maier, Paul V	Director	-	Direct	Sale	1,350	1.25	$1,687.50	31,710	4
2019-01-21	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	599,222	1.75	$1,048,638.50	4,034,594	4
2018-12-04	Garnette, Sophia	Officer	VP, Legal Affairs & Operations	Direct	Sale	10,636	1.54	$16,379.44	267	4
2018-12-03	Kern, Russell	Director,Officer,TenPercentOwner	EVP and CSO	Direct	Sale	1,800	1.67	$3,006.00	178,398	4
2018-10-02	Garnette, Sophia	Officer	VP, Legal Affairs & Operation	Direct	Sale	1,494	1.58	$2,360.52	267	4
2018-08-21	Garnette, Sophia	Officer	VP, Legal Affairs & Operation	Direct	Sale	4,900	1.58	$7,742.00	267	4
2018-08-20	Garnette, Sophia	Officer	VP, Legal Affairs & Operation	Direct	Sale	9,304	1.58	$14,700.32	267	4
2018-07-13	Garnette, Sophia	Officer	VP, Legal Affairs & Operation	Direct	Sale	1,100	1.58	$1,738.00	267	4
2018-07-10	Garnette, Sophia	Officer	VP, Legal Affairs & Operation	Direct	Sale	2,833	1.58	$4,476.14	267	4
2018-06-26	Garnette, Sophia	Officer	VP, Legal Affairs & Operation	Direct	Sale	200	1.59	$318.00	267	4
2018-06-25	Garnette, Sophia	Officer	VP, Legal Affairs & Operation	Direct	Sale	1,200	1.60	$1,920.00	267	4
2017-12-12	Don, Wright	Director	-	Direct	Sale	4,000	1.50	$6,000.00	4,739	4
2017-12-07	Don, Wright	Director	-	Direct	Sale	1,539	1.50	$2,308.50	30,100	4
2017-12-07	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	1,860,810	1.75	$3,256,417.50	3,389,260	4
2017-05-22	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	3,200	1.64	$5,248.00	1,528,450	4
2017-03-22	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	3,000	1.69	$5,070.00	1,525,250	4
2017-03-14	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	2,100	1.59	$3,339.00	1,515,250	4
2016-12-08	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	285,714	1.75	$499,999.50	1,507,150	4
2016-09-14	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	200,000	1.75	$350,000.00	1,221,436	4
2016-08-22	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	154,285	1.75	$269,998.75	1,021,436	4
2016-06-29	Semechkin, Andrey	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	215,000	1.75	$376,250.00	867,151	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2023-03-31

0.00%

Inst. Shares: 20

Shares Outstanding: 8,004,389

2022-12-31

0.00%

Inst. Shares: 20

Shares Outstanding: 8,004,389

2022-09-30

0.00%

Inst. Shares: 20

Shares Outstanding: 8,004,389

2022-06-30

0.00%

Inst. Shares: 20

Shares Outstanding: 8,004,389

2022-03-31

0.00%

Inst. Shares: 20

Shares Outstanding: 8,004,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2023-03-31	20	8,004,389	0.00%
2022-12-31	20	8,004,389	0.00%
2022-09-30	20	8,004,389	0.00%
2022-06-30	20	8,004,389	0.00%
2022-03-31	20	8,004,000	0.00%
2021-12-31	20	7,833,000	0.00%
2021-09-30	20	8,004,000	0.00%
2021-06-30	20	7,767,000	0.00%
2021-03-31	27	7,767,000	0.00%
2020-12-31	20	7,539,089	0.00%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

International Stem Cell CORP (ISCO) — SEC Financial Statements & Analysis

International Stem Cell CORP (ISCO) is a pharmaceutical preparations company, incorporated in DE. International Stem Cell CORP trades on OTC as: ISCO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), International Stem Cell CORP reported a 3.40% year-over-year revenue growth, a Gross Profit Margin of 54.96% (TTM), a Debt-to-Equity ratio of -1.18x, a Price-to-Sales (P/S) ratio of 0.16x (TTM), a Price-to-Book (P/B) ratio of -0.36x (TTM), at a market cap of $1.52M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 3.40%
Gross Profit Margin TTM: 54.96%
Debt To Equity: -1.18x
P/S TTM: 0.16x
P/B TTM: -0.36x
Market Cap: $1.52M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is International Stem Cell CORP in?

International Stem Cell CORP (ISCO) operates in the Pharmaceutical Preparations industry.

What is ISCO's market cap?

International Stem Cell CORP (ISCO) has a market capitalization of $1.52M as of 2026-06-30.

What exchange does ISCO trade on?

International Stem Cell CORP (ISCO) trades on the OTC.

Where is International Stem Cell CORP incorporated?

International Stem Cell CORP is incorporated in DE.